Format

Send to

Choose Destination
J Neuroimmune Pharmacol. 2013 Jun;8(3):477-88. doi: 10.1007/s11481-012-9376-x. Epub 2012 May 16.

Improving the diagnosis and treatment of CRPS: insights from a clinical immunologist's personal experience with an underrecognized neuroinflammatory disorder.

Author information

1
Division of Clinical Immunology and Allergy, University of Toronto, Toronto, Ontario, Canada. binkleyk@smh.ca

Abstract

Complex regional pain syndrome is a neuroinflammatory condition associated with overactive glial cells that can be challenging to diagnose and treat. Early recognition and treatment are thought to be critical for good outcomes, yet many patients experience a delay in diagnosis and have difficulty accessing expert medical care. While there are no universally effective treatments, there are several promising new therapies, but these are not widely available. Some of the specific barriers to diagnosis and treatment are reviewed, with suggestions as to how they might be eliminated, leading to better care for all patients with CRPS.

PMID:
22588663
DOI:
10.1007/s11481-012-9376-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center